Transgene Biotek Ltd — Board Meeting, 07-08-2026: Board Meeting
07-08-2026 | 11:42 am
07-08-2026 | 11:42 am
Transgene Biotek's board approved Q1 FY27 standalone and consolidated results: revenue at ₹0.06 Cr, net loss at ₹0.39 Cr. They also extended the AGM date and appointed M/s. Manisha Dubey & Associates as new Internal Auditors for FY26-27.
No comments yet. Be the first to comment!
